US FDA To Approve Clinical Trials for Type 2 Diabetes By Global Institute of Stem Cell Therapy and Research (GIOSTAR)
Global Institute of Stem Cell Therapy and Research (GIOSTAR) announced today that about the conduction of the clinical trials for type 2 diabetes treatment based through stem cell therapy. These clinical trials on their way of processing to get approval by the Food and Drug Administration (FDA). Dr. Anand Srivastava, who is the chairman and…